{"id":6497,"date":"2012-12-14T13:10:00","date_gmt":"2012-12-14T13:10:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=6497"},"modified":"2021-12-14T13:13:06","modified_gmt":"2021-12-14T13:13:06","slug":"management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/","title":{"rendered":"Management of cutaneous disorders related to inflammatory bowel disease"},"content":{"rendered":"
\n

Zaira Pellicer<\/a>,a<\/sup>\u00a0Jesus Manuel Santiago<\/a>,b<\/sup>\u00a0Alejandro Rodriguez<\/a>,b<\/sup>\u00a0Vicent Alonso<\/a>,a<\/sup>\u00a0Rosario Ant\u00f3n<\/a>,b<\/sup>\u00a0and\u00a0Marta Maia Bosca<\/a>b<\/sup> ,Ann Gastroenterol.<\/a>\u00a02012; 25(1): 21\u201326.<\/p>\n<\/div>\n\n

\n

Almost one-third of patients with inflammatory bowel disease (IBD) develop skin lesions. Cutaneous disorders associated with IBD may be divided into 5 groups based on the nature of the association: specific manifestations (orofacial and metastatic IBD), reactive disorders (erythema nodosum, pyoderma gangrenosum, pyodermatitis-pyostomatitis vegetans, Sweet\u2019s syndrome and cutaneous polyarteritis nodosa), miscellaneous (epidermolysis bullosa acquisita, bullous pemphigoid, linear IgA bullous disease, squamous cell carcinoma-Bowen\u2019s disease, hidradenitis suppurativa, secondary amyloidosis and psoriasis), manifestations secondary to malnutrition and malabsorption (zinc, vitamins and iron deficiency), and manifestations secondary to drug therapy (salicylates, immunosupressors, biological agents, antibiotics and steroids). Treatment should be individualized and directed to treating the underlying IBD as well as the specific dermatologic condition. The aim of this review includes the description of clinical manifestations, course, work-up and, most importantly, management of these disorders, providing an assessment of the literature on the topic.<\/p>\n<\/div>\n\n

\n

Management of cutaneous disorders related to inflammatory bowel disease (nih.gov)<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Zaira Pellicer,a\u00a0Jesus Manuel Santiago,b\u00a0Alejandro Rodriguez,b\u00a0Vicent Alonso,a\u00a0Rosario Ant\u00f3n,b\u00a0and\u00a0Marta Maia Boscab ,Ann Gastroenterol.\u00a02012; 25(1): 21\u201326. Almost one-third of patients with inflammatory bowel disease (IBD) develop skin lesions. Cutaneous disorders associated with IBD may be divided into 5 groups based on the nature of the association: specific manifestations (orofacial and metastatic IBD), reactive disorders (erythema nodosum, pyoderma gangrenosum, […]<\/p>\n","protected":false},"template":"","scientific_tags":[374,463,464],"class_list":["post-6497","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-inflammatory-bowel-disease","scientific_tags-skin","scientific_tags-treament"],"acf":[],"yoast_head":"\nManagement of cutaneous disorders related to inflammatory bowel disease - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Management of cutaneous disorders related to inflammatory bowel disease - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Zaira Pellicer,a\u00a0Jesus Manuel Santiago,b\u00a0Alejandro Rodriguez,b\u00a0Vicent Alonso,a\u00a0Rosario Ant\u00f3n,b\u00a0and\u00a0Marta Maia Boscab ,Ann Gastroenterol.\u00a02012; 25(1): 21\u201326. Almost one-third of patients with inflammatory bowel disease (IBD) develop skin lesions. Cutaneous disorders associated with IBD may be divided into 5 groups based on the nature of the association: specific manifestations (orofacial and metastatic IBD), reactive disorders (erythema nodosum, pyoderma gangrenosum, […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-14T13:13:06+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/\",\"name\":\"Management of cutaneous disorders related to inflammatory bowel disease - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2012-12-14T13:10:00+00:00\",\"dateModified\":\"2021-12-14T13:13:06+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Management of cutaneous disorders related to inflammatory bowel disease - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/","og_locale":"de_DE","og_type":"article","og_title":"Management of cutaneous disorders related to inflammatory bowel disease - Adacyte","og_description":"Zaira Pellicer,a\u00a0Jesus Manuel Santiago,b\u00a0Alejandro Rodriguez,b\u00a0Vicent Alonso,a\u00a0Rosario Ant\u00f3n,b\u00a0and\u00a0Marta Maia Boscab ,Ann Gastroenterol.\u00a02012; 25(1): 21\u201326. Almost one-third of patients with inflammatory bowel disease (IBD) develop skin lesions. Cutaneous disorders associated with IBD may be divided into 5 groups based on the nature of the association: specific manifestations (orofacial and metastatic IBD), reactive disorders (erythema nodosum, pyoderma gangrenosum, […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/","og_site_name":"Adacyte","article_modified_time":"2021-12-14T13:13:06+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/","name":"Management of cutaneous disorders related to inflammatory bowel disease - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2012-12-14T13:10:00+00:00","dateModified":"2021-12-14T13:13:06+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/management-of-cutaneous-disorders-related-to-inflammatory-bowel-disease\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/6497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=6497"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=6497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}